Passage Bio Inc
Passage Bio Inc logo
PASG

Passage Bio Inc (PASG)

$1.222.52%

Market is closed
– opens on 8 PM, 05 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$1.18
Day's Range
$1.24
$1.11
52-Week Range
$7.81
1 month return1.61%
3 month return35.79%
1 year return82.94%
5 year return94.5%

Company Information

Passage Bio, has the mission to provide life-transforming gene therapies for patients with rare, monogenic CNS diseases that replace their suffering with boundless possibility, all while building lasting relationships with the communities it serves. Based in Philadelphia, PA, the company has established a strategic collaboration and licensing agreement with the renowned University of Pennsylvania's Gene Therapy Program to conduct its discovery and IND-enabling preclinical work. This provides the team with enhanced access to a broad portfolio of gene therapy candidates and future gene therapy innovations that Passage Bio then pairs with its deep clinical, regulatory, manufacturing and commercial expertise to rapidly advance its robust pipeline of optimized gene therapies into clinical testing. As the company works with speed and tenacity, Passage Bio is always mindful of patients who may be able to benefit from its therapies.
OrganizationPassage Bio Inc
Employees133
CEODr. William Chou M.D.
IndustryHealth Technology

Analyst Recommendation

based on 7 analysts ratings

Buy
85%
Buy
14%
Hold
0%
Sell

Based on 7 Wall street analysts offering stock ratings for Passage Bio Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 596.72%

Current

$1.22

Target

$8.5

Recommendation Trend

Based on 7 analyst

Current1M Ago3M Ago
Buy
6
12
12
Hold
1
2
3
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
64.9M
Book Value
$4.11
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-3.5
Wall Street Target Price
8.5

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
0.3
Enterprise Value
-118277422
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
0.77

Technicals

Beta
1.13
50 Day MA
1.29
200 Day MA
2.14

Institutional Holdings

Orbimed Advisors, LLC

16.38%

Versant Venture Management LLC

9.09%

New Leaf Venture Partners, L.L.C.

4.58%

Deep Track Capital, LP

4.25%

Vanguard Group Inc

3.7%

Highline Capital Management LLC

2.27%

Discover more

Frequently Asked Questions

What is Passage Bio Inc share price today?

Can Indians buy Passage Bio Inc shares?

How can I buy Passage Bio Inc shares from India?

Can Fractional shares of Passage Bio Inc be purchased?

What are the documents required to start investing in Passage Bio Inc stocks?

What are today’s High and Low prices of Passage Bio Inc?

What are today’s traded volumes of Passage Bio Inc?

What is today’s market capitalisation of Passage Bio Inc?

What is the 52 Week High and Low Range of Passage Bio Inc?

How much percentage Passage Bio Inc is down from its 52 Week High?

How much percentage Passage Bio Inc is up from its 52 Week low?

What are the historical returns of Passage Bio Inc?

Who is the Chief Executive Officer (CEO) of Passage Bio Inc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*